Creatinine Index Linked to CKD Mortality
Prospective UK cohort study links higher creatinine muscle index to lower odds of probable sarcopenia and reduced pre–kidney replacement therapy mortality.
A prospective cohort study involving 2,930 patients with nondialysis chronic kidney disease revealed that a higher creatinine muscle index correlates with lower odds of probable sarcopenia and reduced all-cause mortality prior to kidney replacement therapy. Conducted by Thomas McDonnell, MBChB, from the Donal O’Donoghue Renal Research Centre, the study found significant associations between creatinine muscle index and muscle strength, as well as decreased mortality risk, suggesting its potential as a useful clinical tool in managing kidney disease-related complications.
1. Higher creatinine muscle index reduces odds of probable sarcopenia. 2. The study evaluated 2,930 CKD patients across 16 centers. 3. Significant correlation with muscle strength and mortality rates. 4. Each 100 mg/day increase linked to lower death risk. 5. Observational design limits generalizability. 6. Creatinine muscle index easy to measure, warrants further investigation as a clinical tool.